| Ident. | Authors (with country if any) | Title |
|---|
| 001431 (2006) |
Qanta A. Ahmed [États-Unis] ; Yaseen M. Arabi [Arabie saoudite] ; Ziad A. Memish [Arabie saoudite] | Health risks at the Hajj |
| 002576 (2012) |
Ali M. Zaki [Arabie saoudite] ; Sander Van Boheemen ; Theo M. Bestebroer ; Albert D M E. Osterhaus ; Ron A M. Fouchier | Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. |
| 002581 (2012) |
Mohammed N. Al-Ahdal [Arabie saoudite] ; Ahmed Ali Al-Qahtani ; Salvatore Rubino | Coronavirus respiratory illness in Saudi Arabia. |
| 002632 (2013) |
V. Stalin Raj ; Huihui Mou ; Saskia L. Smits [Pays-Bas] ; Dick H. W. Dekkers ; Marcel A. Müller ; Ronald Dijkman ; Doreen Muth ; Jeroen A. A. Demmers ; Ali Zaki [Arabie saoudite] ; Ron A. M. Fouchier ; Volker Thiel ; Christian Drosten ; Peter J. M. Rottier ; Albert D. M. E. Osterhaus ; Berend Jan Bosch ; Bart L. Haagmans | Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC |
| 002636 (2013) |
Brian Mccloskey [Royaume-Uni] ; Alimuddin Zumla [Royaume-Uni] ; Gwen Stephens [Arabie saoudite] ; David L. Heymann [Royaume-Uni] ; Ziad A. Memish [Arabie saoudite] | Applying lessons from SARS to a newly identified coronavirus |
| 002742 (2013) |
Hisham Momattin [Arabie saoudite] ; Khurram Mohammed [Arabie saoudite] ; Alimuddin Zumla [Royaume-Uni] ; Ziad A. Memish [Arabie saoudite] ; Jaffar A. Al-Tawfiq [États-Unis] | Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy |
| 002815 (2014) |
Z A Memish [Arabie saoudite] ; J A Al-Tawfiq ; H Q Makhdoom ; A A Al-Rabeeah ; A. Assiri ; R F Alhakeem ; F A Alrabiah ; S. Al Hajjar ; A. Albarrak ; H. Flemban ; H. Balkhy ; M. Barry ; S. Alhassan ; S. Alsubaie ; A. Zumla | Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. |
| 002840 (2014) |
Jaffar A. Al-Tawfiq [Arabie saoudite] ; Ziad A. Memish | What are our pharmacotherapeutic options for MERS-CoV? |
| 002884 (2015) |
Mohammed Khalid [Arabie saoudite] ; Fahad Al Rabiah ; Basha Khan ; Abdullah Al Mobeireek ; Taimur S. Butt ; Eid Al Mutairy | Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases. |
| 002927 (2014) |
Jaffar A. Al-Tawfiq [Arabie saoudite, États-Unis] ; Alimuddin Zumla [Arabie saoudite, Royaume-Uni] ; Ziad A. Memish [Arabie saoudite] | Travel implications of emerging coronaviruses: SARS and MERS-CoV |
| 002950 (2014) |
Jaffar A. Al-Tawfiq [Arabie saoudite, États-Unis] ; Alimuddin Zumla [Royaume-Uni, Arabie saoudite] ; Philippe Gautret [France] ; Gregory C. Gray ; David S. Hui [Hong Kong] ; Abdullah A. Al-Rabeeah [Arabie saoudite] ; Ziad A. Memish [Arabie saoudite] | Surveillance for emerging respiratory viruses |
| 002A55 (2015) |
Ali M. Al Shehri [Arabie saoudite] | A lesson learned from Middle East respiratory syndrome (MERS) in Saudi Arabia. |
| 002B64 (2016) |
J A Otter [Royaume-Uni] ; C. Donskey [États-Unis] ; S. Yezli [Arabie saoudite] ; S. Douthwaite [Royaume-Uni] ; S D Goldenberg [Royaume-Uni] ; D J Weber [États-Unis] | Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. |
| 002B85 (2016) |
Diego Forni [Italie] ; Rachele Cagliani [Italie] ; Alessandra Mozzi [Italie] ; Uberto Pozzoli [Italie] ; Nasser Al-Daghri [Arabie saoudite] ; Mario Clerici [Italie] ; Manuela Sironi [Italie] | Extensive Positive Selection Drives the Evolution of Nonstructural Proteins in Lineage C Betacoronaviruses |
| 002C73 (2016) |
Anurodh Shankar Agrawal [États-Unis] ; Xinrong Tao [États-Unis] ; Abdullah Algaissi [États-Unis, Arabie saoudite] ; Tania Garron [États-Unis] ; Krishna Narayanan [États-Unis] ; Bi-Hung Peng [États-Unis] ; Robert B. Couch [États-Unis] ; Chien-Te K. Tseng [États-Unis] | Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus |
| 002C76 (2016) |
Ali Al-Hazmi [Arabie saoudite] | Challenges presented by MERS corona virus, and SARS corona virus to global health. |
| 002C78 (2016) |
Alimuddin Zumla [Royaume-Uni] ; Osman Dar [Royaume-Uni] ; Richard Kock [Royaume-Uni] ; Matthew Muturi [Kenya] ; Francine Ntoumi [Allemagne] ; Pontiano Kaleebu [Ouganda] ; Macete Eusebio [Mozambique] ; Sayoki Mfinanga [Tanzanie] ; Matthew Bates [Zambie] ; Peter Mwaba [Zambie] ; Rashid Ansumana [Sierra Leone] ; Mishal Khan [Royaume-Uni, Singapour] ; Abdulaziz N. Alagaili [Arabie saoudite] ; Matthew Cotten [Royaume-Uni] ; Esam I. Azhar [Arabie saoudite] ; Markus Maeurer [Suède] ; Giuseppe Ippolito [Italie] ; Eskild Petersen [Danemark, Oman] | Taking forward a ‘One Health’ approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential |
| 002E05 (2017) |
Ajamaluddin Malik [Arabie saoudite] ; Mohammad A. Alsenaidy [Arabie saoudite] | MERS‐CoV papain-like protease (PLpro): expression, purification, and spectroscopic/thermodynamic characterization |
| 002E38 (2017) |
Mohammad K. Parvez [Arabie saoudite] ; Shama Parveen | Evolution and Emergence of Pathogenic Viruses: Past, Present, and Future. |
| 002E43 (2017) |
Ali A. Rabaan [Arabie saoudite] ; Shamsah H. Alahmed [Arabie saoudite] ; Ali M. Bazzi [Arabie saoudite] ; Hatem M. Alhani [Arabie saoudite] | A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective. |
| 002F30 (2018) |
Ali Al-Hazmi [Arabie saoudite] ; Ibrahim Gosadi [Arabie saoudite] ; Ali Somily [Arabie saoudite] ; Sarah Alsubaie [Arabie saoudite] ; Abdulaziz Bin Saeed [Arabie saoudite] | Knowledge, attitude and practice of secondary schools and university students toward Middle East Respiratory Syndrome epidemic in Saudi Arabia: A cross-sectional study. |
